Suppr超能文献

蛋白酶激活受体 1(PAR1)信号转导脱敏可通过人血小板中的 PAR4 信号转导来拮抗。

Protease-activated receptor 1 (PAR1) signalling desensitization is counteracted via PAR4 signalling in human platelets.

机构信息

Department of Clinical and Experimental Medicine, Division of Clinical Chemistry, Medical Faculty, University of Linköping, University Hospital, Linköping 581 85, Sweden.

出版信息

Biochem J. 2011 Jun 1;436(2):469-80. doi: 10.1042/BJ20101360.

Abstract

PARs (protease-activated receptors) 1 and 4 belong to the family of G-protein-coupled receptors which induce both G(α12/13) and G(αq) signalling. By applying the specific PAR1- and PAR4-activating hexapeptides, SFLLRN and AYPGKF respectively, we found that aggregation of isolated human platelets mediated via PAR1, but not via PAR4, is abolished upon homologous receptor activation in a concentration- and time-dependent fashion. This effect was not due to receptor internalization, but to a decrease in Ca²⁺ mobilization, PKC (protein kinase C) signalling and α-granule secretion, as well as to a complete lack of dense granule secretion. Interestingly, subthreshold PAR4 activation rapidly abrogated PAR1 signalling desensitization by differentially reconstituting these affected signalling events and functional responses, which was sufficient to re-establish aggregation. The lack of ADP release and P2Y₁₂ receptor-induced G(αi) signalling accounted for the loss of the aggregation response, as mimicking G(αi/z) signalling with 2-MeS-ADP (2-methylthioadenosine-5'-O-diphosphate) or epinephrine (adrenaline) could substitute for intermediate PAR4 activation. Finally, we found that the re-sensitization of PAR1 signalling-induced aggregation via PAR4 relied on PKC-mediated release of both ADP from dense granules and fibrinogen from α-granules. The present study elucidates further differences in human platelet PAR signalling regulation and provides evidence for a cross-talk in which PAR4 signalling counteracts mechanisms involved in PAR1 signalling down-regulation.

摘要

蛋白酶激活受体 (PARs) 1 和 4 属于 G 蛋白偶联受体家族,可诱导 G(α12/13)和 G(αq)信号转导。通过应用特异性 PAR1 和 PAR4 激活六肽 SFLLRN 和 AYPGKF,我们发现,通过 PAR1 介导的人血小板分离物的聚集,而不是通过 PAR4 介导的聚集,在同源受体激活时,以浓度和时间依赖的方式被废除。这种效应不是由于受体内化,而是由于 Ca²⁺动员、PKC(蛋白激酶 C)信号转导和α-颗粒分泌减少,以及致密颗粒分泌完全缺失。有趣的是,亚阈值 PAR4 激活通过差异重建这些受影响的信号事件和功能反应,迅速消除 PAR1 信号脱敏,足以重新建立聚集。缺乏 ADP 释放和 P2Y₁₂受体诱导的 G(αi)信号转导是聚集反应丧失的原因,因为用 2-MeS-ADP(2-甲基硫腺苷-5'-O-二磷酸)或肾上腺素(肾上腺素)模拟 G(αi/z)信号转导可以替代中间 PAR4 激活。最后,我们发现,通过 PAR4 重新敏化 PAR1 信号诱导的聚集依赖于 PKC 介导的致密颗粒中 ADP 和α-颗粒中纤维蛋白原的释放。本研究进一步阐明了人血小板 PAR 信号转导调节的差异,并提供了证据表明 PAR4 信号转导相互作用可以抵消 PAR1 信号转导下调所涉及的机制。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验